Rothschild Investment »

ADC Therapeutics SA shares owned by Rothschild Investment

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2025-12-31 $35 10 3.50

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Microsoft Corp Stock (MSFT)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Blackstone Stock (BX)
Invesco Rafi Us 1000 Etf Etf (PRF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Amazon Stock (AMZN)
Abbvie Stock (ABBV)
Capital Group Dividend Growers Etf Etf (CGDG)
Johnson & Johnson Stock (JNJ)
Meta Platforms Inc Cl A Stock (META)
Chevron Corporation Stock (CVX)

View all positions for Rothschild Investment

Top funds holding ADC Therapeutics SA

Redmile Group
TCG Crossover Management
Prosight Management
OrbiMed Advisors
Nantahala Capital Management
BlackRock
Point72 Asset Management
Eventide Asset Management
Goldman Sachs Group
State Street Corporation
Vanguard Group
Geode Capital Management
Platinum Investment Mangement
Bnp Paribas Arbitrage, Snc
Blue Owl Capital Holdings

View all funds holding ADC Therapeutics SA